Because methylation constrains cellular plasticity by restricting the genome to the specific functions of terminally differentiated cells67, future work will determine whether SFRP1-mediated methylome remodeling enduringly locks GBM cells in a quiescent state, offering a potential therapeutic avenue. This evidence concerns the gene SFRP1 and glioblastoma.